Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

 323.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 325.00
  • 52 Week Low: 147.50
  • Currency: UK Pounds
  • Shares Issued: 46.97m
  • Volume: 5,368
  • Market Cap: £151.70m
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
86.28% below the market average86.28% below the market average86.28% below the market average86.28% below the market average86.28% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
1yr Revenue Growth
24.89% above the market average24.89% above the market average24.89% above the market average24.89% above the market average24.89% above the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
5.36% below the market average5.36% below the market average5.36% below the market average5.36% below the market average5.36% below the market average
52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average
Price Book Ratio
79.99% below the market average79.99% below the market average79.99% below the market average79.99% below the market average79.99% below the market average
29.82% below the sector average29.82% below the sector average29.82% below the sector average29.82% below the sector average29.82% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
82.92% above the market average82.92% above the market average82.92% above the market average82.92% above the market average82.92% above the market average
63.33% above the sector average63.33% above the sector average63.33% above the sector average63.33% above the sector average63.33% above the sector average
Price Chg 3m
92.12% above the market average92.12% above the market average92.12% above the market average92.12% above the market average92.12% above the market average
70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
51.60% above the market average51.60% above the market average51.60% above the market average51.60% above the market average51.60% above the market average
32.20% above the sector average32.20% above the sector average32.20% above the sector average32.20% above the sector average32.20% above the sector average
Momentum 20
7.55% below the market average7.55% below the market average7.55% below the market average7.55% below the market average7.55% below the market average
25.42% below the sector average25.42% below the sector average25.42% below the sector average25.42% below the sector average25.42% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
57.87% below the market average57.87% below the market average57.87% below the market average57.87% below the market average57.87% below the market average
7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
12.82% below the market average12.82% below the market average12.82% below the market average12.82% below the market average12.82% below the market average
49.15% above the sector average49.15% above the sector average49.15% above the sector average49.15% above the sector average49.15% above the sector average
Forecast EPS
26.34% below the market average26.34% below the market average26.34% below the market average26.34% below the market average26.34% below the market average
23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
12.28% above the market average12.28% above the market average12.28% above the market average12.28% above the market average12.28% above the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Operating Profit Loss
84.29% below the market average84.29% below the market average84.29% below the market average84.29% below the market average84.29% below the market average
42.37% below the sector average42.37% below the sector average42.37% below the sector average42.37% below the sector average42.37% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
2.59% above the market average2.59% above the market average2.59% above the market average2.59% above the market average2.59% above the market average
13.79% above the sector average13.79% above the sector average13.79% above the sector average13.79% above the sector average13.79% above the sector average
Cash
17.69% below the market average17.69% below the market average17.69% below the market average17.69% below the market average17.69% below the market average
27.59% below the sector average27.59% below the sector average27.59% below the sector average27.59% below the sector average27.59% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
97.66% below the market average97.66% below the market average97.66% below the market average97.66% below the market average97.66% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Buys 1y
81.83% above the market average81.83% above the market average81.83% above the market average81.83% above the market average81.83% above the market average
62.16% above the sector average62.16% above the sector average62.16% above the sector average62.16% above the sector average62.16% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
39.42% above the market average39.42% above the market average39.42% above the market average39.42% above the market average39.42% above the market average
3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Ergomed Market Data

Currency UK Pounds
Share Price 323.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 325.00
52 Week Low 147.50
Volume 5,368
Shares Issued 46.97m
Market Cap £151.70m
Beta 0.01

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
39.85% below the market average39.85% below the market average39.85% below the market average39.85% below the market average39.85% below the market average
28.81% above the sector average28.81% above the sector average28.81% above the sector average28.81% above the sector average28.81% above the sector average
Price Trend
97.71% above the market average97.71% above the market average97.71% above the market average97.71% above the market average97.71% above the market average
90.00% above the sector average90.00% above the sector average90.00% above the sector average90.00% above the sector average90.00% above the sector average
Income Not Available
Growth
42.33% below the market average42.33% below the market average42.33% below the market average42.33% below the market average42.33% below the market average
89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for 21-Aug-2019

Time Volume / Share Price
16:35 5,000 @ 322.50p
11:45 89 @ 322.50p
08:15 279 @ 320.50p

Ergomed Key Personnel

COO Jan Petracek

Top of Page